1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

AngioDynamics

Anonymous board for AngioDynamics


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    3
    Views:
    783
  2. anonymous
    Replies:
    0
    Views:
    262
  3. anonymous
    Replies:
    4
    Views:
    1,696
  4. anonymous
    Replies:
    1
    Views:
    905
  5. Anonymous
    Replies:
    9
    Views:
    10,748
  6. anonymous
    Replies:
    1
    Views:
    949
  7. anonymous
    Replies:
    0
    Views:
    713
  8. anonymous
    Replies:
    3
    Views:
    3,336
  9. anonymous
    Replies:
    2
    Views:
    1,958
  10. anonymous
    Replies:
    5
    Views:
    4,065
  11. anonymous
    Replies:
    0
    Views:
    1,355
  12. anonymous
    Replies:
    8
    Views:
    4,880
  13. anonymous
    Replies:
    0
    Views:
    1,206
  14. anonymous
    Replies:
    9
    Views:
    4,447
  15. Anonymous
    Replies:
    147
    Views:
    56,420
  16. Anonymous
    Replies:
    28
    Views:
    23,896
  17. Anonymous
    Replies:
    2
    Views:
    5,526
  18. anonymous
    Replies:
    0
    Views:
    2,589
  19. anonymous
    Replies:
    5
    Views:
    3,942
  20. Anonymous
    Replies:
    1
    Views:
    2,628

Thread Display Options

Loading...